Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Stephanie Chhun"'
Autor:
Elise Payen, Antoine Neuraz, Letizia Zenzeri, Cécile Talbotec, Elie Abi Nader, Lucienne Chatenoud, Stephanie Chhun, Olivier Goulet, Frank M. Ruemmele, Bénédicte Pigneur
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 76:166-173
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3ad4d38ea783fc745c176bacc0b00c3
https://doi.org/10.1097/mpg.0000000000003643
https://doi.org/10.1097/mpg.0000000000003643
Autor:
Elise, Payen, Antoine, Neuraz, Letizia, Zenzeri, Cécile, Talbotec, Elie, Abi Nader, Lucienne, Chatenoud, Stephanie, Chhun, Olivier, Goulet, Frank M, Ruemmele, Bénédicte, Pigneur
Publikováno v:
Journal of pediatric gastroenterology and nutrition.
European Crohn's Colitis Organization (ECCO) and the European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines recommend the early use of anti-TNF biologicals in pediatric Crohn disease (CD) patients with positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e40f932ed2f69d0d58d8cb22110158af
https://pubmed.ncbi.nlm.nih.gov/36305799
https://pubmed.ncbi.nlm.nih.gov/36305799
Autor:
Celine Verstuyft, Ilana Peretti, Robert Wortelboer, G. Simoneau, Jean Francois Bergmann, Nathalie Rizzo-Padoin, Stephanie Chhun, Laurent Becquemont, Stephane Mouly, Alan Swaisland
Publikováno v:
British Journal of Clinical Pharmacology. 68:226-237
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • The response to gefitinib is variable and could be explained partly by the interindividual variability in gefitinib exposure. • Gefitinib is mainly metabolized by CYP3A4 and CYP2D6, and is to a lesser ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd706400b2fcf24fc9ba327fb9294585
https://doi.org/10.1111/j.1365-2125.2009.03438.x
https://doi.org/10.1111/j.1365-2125.2009.03438.x
Autor:
Stéphanie Chhun, Mathieu Trauchessec, Sophie Melicine, Frédéric Nicolas, Agathe Miele, Srboljub Lukic, Estelle Vilain, Lucile Amrouche, Dorothée Lebert, Dany Anglicheau, Eric Tartour, Julien Zuber
Publikováno v:
Biomedicines, Vol 11, Iss 11, p 2955 (2023)
Belatacept, a CTLA4-Ig, was designed to prevent rejection and graft loss in kidney transplant recipients. This immunotherapy showed a long-term clinical benefit mainly on renal function and better glycemic control but was also associated with a highe
Externí odkaz:
https://doaj.org/article/0e929a37c0df40c7945df5fb449444dc
Autor:
Laurent Becquemont, Stephanie Chhun, Jean François Bergmann, Stéphane Mouly, Nathalie Rizzo-Padoin, Guy Simoneau, Céline Verstuyft
Publikováno v:
ResearcherID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42b98493c74620f3e581b961bc9ce453
https://doi.org/10.1097/jcp.0b013e3182549c0c
https://doi.org/10.1097/jcp.0b013e3182549c0c
Autor:
Annie Harroche, Thibaud Sefiane, Maximilien Desvages, Delphine Borgel, Dominique Lasne, Caterina Casari, Ivan Peyron, Laurent Frenzel, Stéphanie Chhun, Peter J. Lenting, Cécile Bally
Publikováno v:
Haematologica, Vol 106, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/a7a29d0476524648a0bb1ef6325aef3f